Sandoz Canada Overview
- Founded
-
1980

- Status
-
Acquired/Merged
- Employees
-
600

- Latest Deal Type
-
M&A
- Financing Rounds
-
2
Sandoz Canada General Information
Description
Manufacturer of injectable and ophthalmic pharmaceutical products. The company develops, manufactures, and distributes injectable and ophthalmic generic pharmaceutical products for the hospital and retail markets. It also provides pharmaceuticals, biopharmaceuticals, and anti-infectives.
Contact Information
Website
www.sandoz.ca
Formerly Known As
Sabex
Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Primary Industry
Pharmaceuticals
Acquirer
Primary Office
- 145, Jules-Léger
- Boucherville, Quebec J4B 7K8
- Canada
+1 (450) 000-0000
Sandoz Canada Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Sandoz Canada Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Financing
Details
Manufacturer of injectable and ophthalmic pharmaceutical products. The company develops, manufactures, and distributes i
Pharmaceuticals
Boucherville, Canada
600
As of 2009
0000
0000-00-00
000000&0
Sandoz Canada Competitors (20)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
GlaxoSmithKline Consumer Nigeria | Corporation | Lagos, Nigeria | 00 | |||
000000 000000 0000 | Formerly VC-backed | Gothenburg, Sweden | 00 | 000.00 | 000000000 | 000.00 |
000000 00000000000 | Corporate Backed or Acquired | Chicago, IL | 000 | 00000 | 000000&0 | 00000 |
000 00000000000000 | Formerly PE-Backed | Ramapo, NY | 0000 | 000.00 | 0000000000. | |
0000000000 0000000 | Corporation | Ingelheim am Rhein, Germany | 00000 |
Sandoz Canada Executive Team (4)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Bruce Levins | Vice President, Operations |
Sandoz Canada Signals
Sandoz Canada Former Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|